Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 910 of 1,261
  1. US 8247598

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  2. US 8247225

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  3. US 8247393

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  4. US 8247181

    Borrelia diagnostics and screening methods

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  5. US 8247443

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  6. US 8247403

    Benzoxazepine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  7. US 8246969

    Compositions containing aromatic aldehydes and their use in treatments

    SkinMedica, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  8. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  9. US 8247532

    Deuterated hepatitis C protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  10. US 8246971

    Compositions containing aromatic aldehydes and their use in treatment

    SkinMedica, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  11. US 8247399

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  12. US 8247228

    Method of inducing memory B cell development and terminal differentiation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  13. US 8246987

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  14. US 8247602

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  15. US 8247183

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  16. US 8246931

    Development of a quail embryo model for the detection of botulinum toxin

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  17. US 8246952

    Method of increasing radiation sensitivity by inhibition of beta one integrin

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  18. US 8242112

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  19. US 8242135

    Biphenyl derivatives

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  20. US 8242138

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  21. US 8242142

    Cyclohexylamines, phenylamines and uses thereof

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  22. US 8242149

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  23. US 8242164

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  24. US 8242156

    Linked dibenzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.